Filer Snapshot

Adimab, LLC SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001545672.

Entity Type

Company

Total Filings

14

Latest Filing

29 Dec 2025

Industry

n/a

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Create free account to save and revisit this page

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Go to latest filings table Open reporting owner context
Source: SEC Schedule 13D/G

SCHEDULE 13D/A filed on 29 Dec 2025 for CIK 0001545672.

View Source Filing
Business address
7 Lucent Drive, Lebanon, NH, 03766
Top holdings (ownership)
IVVD
Top holdings (Schedule 13D)
IVVD
State of incorporation
DE
Fiscal year end
31 December

Quick Takeaways

  • Adimab, LLC is an SEC filer tracked under CIK 0001545672.
  • 14 filings are listed on this profile.
  • Common form coverage includes SCHEDULE 13D/A, 144, 4 and more.

What Changed

  • Latest filing: SCHEDULE 13D/A filed on 29 Dec 2025.
  • Report period: not specified in filing header.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC Schedule 13D/G

SCHEDULE 13D/A filed on 29 Dec 2025 for CIK 0001545672.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed SCHEDULE 13D/A can change the filing history, ownership context, or next research path for Adimab, LLC.

Latest source-backed update
SCHEDULE 13D/A filed 29 Dec 2025
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: SCHEDULE 13D/A filed 29 Dec 2025.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Jump to save and follow actions Open latest filings table

Latest update

What changed recently for Adimab, LLC

New filing available

Latest Schedule 13D/G period: 23 Dec 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

29 Dec 2025

Page type

Filer profile

Latest period

23 Dec 2025

Schedule 13D/G context is visible from filings filed on 29 Dec 2025.

Open filer profile Browse recent public updates

Benchmark Context

Benchmark context for this company

Adimab, LLC has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest Schedule 13D/G period: 23 Dec 2025. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

Filer Overview

Adimab, LLC has filed 14 SEC EDGAR filings since 02 Apr 2012. Common forms include SCHEDULE 13D/A, 144, 4, SC 13D/A and more.

Reporting owner transactions Latest 13F filings

Latest Filings

Recent SEC filings for Adimab, LLC with direct links to document and filing folders.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 29 Dec 2025
144 Open 144 document View SEC filing for 144 23 Dec 2025
SCHEDULE 13D/A Open SCHEDULE 13D/A document View SEC filing for SCHEDULE 13D/A 19 Nov 2025
144 Open 144 document View SEC filing for 144 17 Nov 2025
4 Open 4 document View SEC filing for 4 4 22 Jan 2024 19 Jan 2024 001-40703
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 22 Jan 2024
144 Open 144 document View SEC filing for 144 19 Jan 2024
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 24 Jun 2022
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A SC 13D/A 26 Apr 2022
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 01 Apr 2022 03 Mar 2022 001-40703
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 30 Mar 2022
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 12 Aug 2021 10 Aug 2021 001-40703
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 05 Aug 2021 05 Aug 2021 001-40703
D Open D document View SEC filing for D 02 Apr 2012 021-176042

About this filer

Adimab, LLC files with the SEC under CIK 0001545672. This page aggregates EDGAR filings and related ownership activity.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.